Herd Immunity as a Coronavirus Pandemic Strategy

Researchers Investigate What COVID-19 Does to the Heart; "Important Conversations" Are Needed to Explain the Nocebo Effect; Therapists Donate Their Time to Counsel Distressed Health Care Workers Relat...

23 Helmi 202123min

CDC Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss the agency's response to emerging SARS-CoV-2 variants, implications for the planned vaccine mobilization strategy, t...

19 Helmi 202130min

Paul A. Offit, MD, of The Children's Hospital of Philadelphia returns to JAMA's Q&A series to provide an update on the emergence of COVID-19 variants and their implications for vaccine development, in...

15 Helmi 202132min

As US vaccine distribution expands to include younger healthier populations, questions about vaccine safety in women of childbearing age have become more urgent. University of Texas Southwestern Medic...

10 Helmi 202134min

Natural experiments comparing coronavirus spread on ships and in hair salons with vs without face masks point to the importance of wearing masks for curbing SARS-CoV-2 spread. John T. Brooks, MD, chie...

10 Helmi 202129min

Interview with Lawrence O. Gostin, JD, author of Mandating COVID-19 Vaccines

9 Helmi 202123min

2021 has brought news of emerging SARS-CoV-2 genetic variants that increase transmissibility. Will they diminish vaccine efficacy and lead us to lose pandemic control? University of Michigan's Adam La...

8 Helmi 202127min

NIAID Director Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss Shifts in the US pandemic response under the Biden administration Emerging genetic variants and implications for vaccine e...

5 Helmi 202123min